Todd Bazemore
2021
In 2021, Todd Bazemore earned a total compensation of $1.3M as President and Chief Operating Officer at Kala Pharmaceuticals.
Compensation breakdown
| Bonus | $171,457 |
|---|---|
| Option Awards | $483,131 |
| Salary | $489,878 |
| Stock Awards | $188,650 |
| Other | $10,240 |
| Total | $1,343,356 |
Bazemore received $489.9K in salary, accounting for 36% of the total pay in 2021.
Bazemore also received $171.5K in bonus, $483.1K in option awards, $188.7K in stock awards and $10.2K in other compensation.
Rankings
In 2021, Todd Bazemore's compensation ranked 7,688th out of 12,405 executives tracked by ExecPay. In other words, Bazemore earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,688 out of 12,405 | 38th |
Division Manufacturing | 3,386 out of 5,494 | 38th |
Major group Chemicals And Allied Products | 1,499 out of 2,369 | 37th |
Industry group Drugs | 1,333 out of 2,090 | 36th |
Industry Pharmaceutical Preparations | 982 out of 1,537 | 36th |
Source: SEC filing on March 13, 2023.
Bazemore's colleagues
We found two more compensation records of executives who worked with Todd Bazemore at Kala Pharmaceuticals in 2021.